Ann: Receipt of notice under sec249D , page-2

Published by Reuters http://www.reuters.com/finance/stocks/companyOfficers?symbol=AAQ.AX&WTmodLOC=C4-Officers-5 .....

" Mr. Keong Chan serves as Non-Executive Director and Comapny Secretary of AAQ Holdings Limited since October 7, 2010. Mr. Chan spent seven years with Big 4 accounting firms in Sydney, Canberra and Perth where in his last role he was national manager the Australian International Trade practice involving the coordination of teams across Australia to perform due diligence on private equity transactions and analysis of establishing operations in Australia including cost minimisation programs and other restructiong activities. Since 2007, Mr. Chan has provided advice to a number of unlisted and listed companies on corporate matters in relation to IPOs, back door listings, mergers and acquisitions, takeovers/divestments and is also a representative for overseas funds/Investment banks and mining conglomerates. He is currently a director of Soil Sub Technologies Limited, AAQ Limited ( soon to relist on the ASX )and Charterhouse Capital Pty Ltd which provides capital raising and corporate advisory services to unlisted and listed entities. Mr. Chan holds a Bachelor of Commerce and a Masters of International Law. "

The following was published by BioTech Daily Nov 12 2010...

" ACUVAX
Murdoch Capital says it has become a substantial shareholder in Acuvax with the
acquisition of 93,000,000 shares or 9.9 percent of the company.
Murdoch Capital said it acquired the shares today as The Glovac Super Fund for
$139,500 or an average price of 0.15 cents a share.
The initial substantial shareholder notice said Patrick Glovac of Kintail Road, Apple Cros
Western Australia was the sole shareholder and director of Murdoch Capital.
In a separate announcement, Syracuse Capital as the Tenacity Trust said it had become a
substantial shareholder in Acuvax with the acquisition of 93,000,000 shares or 9.9 percent
of the company at the same price as Murdoch Capital.
The initial substantial shareholder notice said Rocco Tassone of Northern Highway,
Middle Swan, Western Australia was the sole shareholder and director of Murdoch
Capital.
Acuvax was unchanged at 0.2 cents having traded as low as 0.15 cents, with 400,555.671
shares traded. Acuvax has 935,095,319 shares on issue."

Maybe Mr Chan ( who as far as I can tell is not associated with any major shareholder...correct me if Im wrong ) is spending too much time with AAQ and SOI and the board at ACU have decided that Mr Tassone being a Director of a major shareholder will be more focused on the activities of ACU ?

ACU baby shakin that....

Cheers